TLR3 agonists, as immunoadjuvant, have been applied for adjuvant immunotherapy of some tumors.
TLR3激动剂作为免疫佐剂已应用到某些肿瘤的辅助性免疫治疗。
This is due to the addition of mucosal immunoadjuvant LTB. This indicates that LTB can enhance the mucosal system response.
这是由于添加了黏膜免疫佐剂LTB的缘故，表明LTB能加强黏膜系统反应。
This is due to the addition of mucosal immunoadjuvant LTB. This indicates that LTB can enhance the mucosal system response.
这是由于添加了黏膜免疫佐剂LTB的缘故，表明LTB能加强黏膜系统反应。
应用推荐